ACRS 8-K 2026-01-12

Aclaris Therapeutics, Inc. (ACRS) 8-K dated 2026-01-12 — accession 0001104659-26-002694. This URL is the filing, not the ACRS hub.

Aclaris Therapeutics, Inc. (ACRS) is a biotechnology company listed on NASDAQ.

Aclaris Therapeutics, Inc. filed a 8-K on 2026-01-12. Accession 0001104659-26-002694.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.

Not investment advice. The ACRS SEC hub lists recent forms. The stock page is the research view.